Laekna

• NCT07787520

  Phase 1, Not yet recruiting, 150 people, 26 Aug 2026

• NCT04851613

  Phase 3, Active, not recruiting, 256 people, 20 Apr 2021

• NCT04374630

  Phase 2, Completed, 150 people, 5 May 2020

• NCT04060394

  Phase 1/2, Completed, 49 people, 19 Aug 2019

• Licence

  Vasque BIO, 10 Jun 2026

• Licence

  Qilu Pharma, 12 Nov 2025

• Financing

  10 Sept 2025

• Financing

  21 Nov 2024

• Eli Lilly and Company

  Collaboration, 20 Nov 2024

• IPO filing

  16 Jun 2023

Sources: www1.hkexnews.hk